Prognostic value of survivin expression in Wilms tumor

Journal of B.U.ON.

Volumn 17, Issue 1, 2012, Pages 168-173

  Basta Jovanovic, G ^a   Radojevic Skodric, Sanja ^a   Brasanac, D ^a   Djuricic, S ^b   Milasin, J ^c   Bogdanovic, L ^a   Opric, D ^a   Savin, M ^d   Baralic, I ^c   Jovanovic, M ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Mother and Child Health Institute Belgrade rs   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

^d CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Apoptosis; Expression; Prognostic value; Survivin; Wilms tumor

Indexed keywords

SURVIVIN;

ARTICLE; CELL NUCLEUS; CHILD; CONTROLLED STUDY; CYTOPLASM; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY EPITHELIUM; KIDNEY PARENCHYMA; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; PRESCHOOL CHILD; PROGNOSIS; PROTEIN EXPRESSION; STROMA;

CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INHIBITOR OF APOPTOSIS PROTEINS; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; PROGNOSIS; WILMS TUMOR;

EID: 84859829280     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Li F, Ambrosisni G, Chu EY et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584. (Pubitemid 28563719)
2. Xu Y, Fang F, Ludewig G et al. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 2004; 23: 527-537. (Pubitemid 39244331)
3. Schmitz M, Diestelkoetter P, Weigle B et al. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 2000; 60: 4845-4849.
4. Yamamoto T, Tanigawa N. The role of survivin as a new target of diagnosis and treatment in human cancer. Med Electron Microsc 2001; 34: 207-212.
5. Breslow N, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms' tumour: report from the National Wilms' Tumour Study. Cancer Res 1988; 48: 1653-1657. (Pubitemid 18091222)
6. Breslow NE, Langholz B. Childhood cancer incidence: geographical and temporal variations. Int J Cancer 1983; 32: 703-716. (Pubitemid 14214915)
7. Matsunaga E. Genetics of Wilms' tumour. Hum Genet 1981; 57: 231-246.
8. Exelby PR. Wilms' tumour 1991. Clinical evaluation and treatment. Urol Clin North Am 1991; 18: 589-597.
9. Vujanic MG, Sandstedt B, Harms D, Kelsey A, Leuschner I, de Kraker J; SIOP Nephroblastoma Scientific Committee. Revised International Society of Pediatric Oncology (SIOP) working classification of renal tumours of childhood. Med Pediatr Oncol 2002; 38: 79-82. (Pubitemid 34113435)
10. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7: 542-547. (Pubitemid 33127139)
11. Iskam A, Kageyama H, Takada N et al. High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 2000; 19: 617-623. (Pubitemid 30102912)
12. Hattori M, Sakamoto H, Satoh K et al. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 2001; 169: 155-164. (Pubitemid 32595563)
13. Hoffman WH, Biade S, Zilfou JT et al. Transcriptional repression of the antiapoptotic survivin gene by wild type p53. J Biol Chem 2002; 277: 3247-3257. (Pubitemid 34953189)
14. Zhang T, Otevrel T, Gao Z et al. Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 61: 8664-8667. (Pubitemid 34013874)
15. Miller MA, Karacay B, Breslow HE et al. Prognostic value of quantifying apoptosis factor expression in favorable histology Wilms tumours. J Pediatr Hematol Oncol 2005; 27: 11-14. (Pubitemid 40175955)
16. Ito T, Shiraki K, Sugimoto K et al. Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 2000; 31: 1080-1085. (Pubitemid 30233232)
17. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F et al. Prognostic value of nuclear survivin expression in esophageal squamous cell carcinoma. Br J Cancer 2003; 88: 115-119. (Pubitemid 36241227)
18. Tringler B, Lehner R, Shroyer AL, Shroyer KR. Immunohistochemical localization of survivin in serous tumours of the ovary. Appl Immunohistochem Mol Morphol 2004; 12: 40-43. (Pubitemid 38332318)
19. Okada E, Murai Y, Matsui K et al. Survivin expression in tumour cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 2001; 163: 109-116. (Pubitemid 32121836)
20. Skagias L, Politi E, Karameris A et al. Survivin expression as a strong indicator of recurrence in urothelial bladder cancer. Predictive value of nuclear versus cytoplasmic staining. Anticancer Res 2009; 29: 4163-4167.
21. Lehner R, Lucia MS, Jarboe EA et al. Immunohistochemical localization of the LAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol 2002; 10: 134-138. (Pubitemid 34553169)
22. Altura RA, Olshefski RS, Jiang Y, Boue DR. Nuclear expression of survivin in pediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade. Br J Cancer 2003; 89: 1743-1749. (Pubitemid 37464149)
23. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I. Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 2002; 184: 105-116. (Pubitemid 34718112)